(2026). Baseline Sleep Quality and Objective Response in HCC Patients Treated with TACE Combined with Lenvatinib and PD-1 Inhibitors: A Secondary Analysis of a Prospectively Registered Observational Cohort. Journal of Hepatocellular Carcinoma.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Baseline Sleep Quality and Objective Response in HCC Patients Treated with TACE Combined with Lenvatinib and PD-1 Inhibitors: A Secondary Analysis of a Prospectively Registered Observational Cohort."
Journal of Hepatocellular Carcinoma 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Baseline Sleep Quality and Objective Response in HCC Patients Treated with TACE Combined with Lenvatinib and PD-1 Inhibitors: A Secondary Analysis of a Prospectively Registered Observational Cohort."
Journal of Hepatocellular Carcinoma, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.